Glucocorticoids are one of the most common classes of drugs used to treat a diverse variety of inflammatory and autoimmune disorders. Despite their effects, long-term therapy exposes patients to multiple side effects, such as weight gain, high blood pressure, adrenal insufficiency, osteoporosis and a high risk of infections. We present the case of a 61-year-old female with osteoporosis secondary to glucocorticoid therapy, adrenal insufficiency, new-onset diabetes mellitus and mixed dyslipidemia, manifestations that occurred as a result of self-administration of Medrol for one year. The patient presented to the hospital for thoracic back pain, being sent to the endocrinologist due to radiological changes suggestive of vertebral compressions.

Burnout syndrome refers to the appearance of a physical and mental exhaustion state that occurs as a result of a high stress level, associated with excessive workload. Burnout is characterized by three components- emotional exhaustion, depersonalization and personal accomplishment. Its diagnosis is established by using the Maslach Burnout Inventory (MBI). According to MBI, burnout is defined by the presence of a high level of emotional exhaustion and depersonalization while personal accomplishment is low. The prevention and treatment of burnout syndrome includes lifestyle changing measures, mindfulness, mental wellness programmes and cognitive behavioural therapy.